Ebola Therapeutics

Awarded Award Notice Posted

Solicitation number
17-100-SOL-00014
Agency
Immediate Office of the Secretary Department of Health and Human Services
Awarded
to Regeneron Pharmaceuticals Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
HHSO100201700016C Federal contract award
NAICS code
541711 Research and Development in Biotechnology
PSC
Not on record

Notice details come from SAM.gov. Updated .

Notice text

4 versions

Update #4 · Latest ·

Added: Jun 14, 2017 2:37 pm UPDATE: AMENDMENT #2 IS NOW POSTED. PLEASE SEE ATTACHMENT FOR MORE DETAILS.

Update #3 ·

Added: Apr 18, 2017 9:24 am Modified: May 24, 2017 7:19 pmTrack Changes UPDATE May 24, 2017: UPDATE: AMENDMENT #1 IS NOW POSTED.

UPDATE May 8, 2017: THIS IS A SOLICITATION NOTICE. PLEASE SEE ATTACHMENT.

April 18, 2017: THIS IS A PRE-SOLICITATION NOTICE. PLEASE SEE ATTACHMENT.

Update #2 ·

Added: Apr 18, 2017 9:24 am Modified: May 08, 2017 10:52 amTrack Changes UPDATE May 8, 2017: THIS IS A SOLICITATION NOTICE. PLEASE SEE ATTACHMENT.

April 18, 2017: THIS IS A PRE-SOLICITATION NOTICE. PLEASE SEE ATTACHMENT.

Update #1 ·

Added: Apr 18, 2017 9:24 am April 18, 2017: THIS IS A PRE-SOLICITATION NOTICE. PLEASE SEE ATTACHMENT.

Attachments

Files attached to this notice, newest first
File Type Posted
Amendment_2.pdf PDF
EBOLA_Therapeutics_Amendment__1.pdf PDF
Ebola_Therapeutics_RFP.pdf PDF
Ebola_Therapeutics_Pre-Sol_Notice.pdf PDF

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity